Design Therapeutics (NasdaqGS:DSGN) Q1 2026 Earnings call April 28, 2026 08:30 AM ET Company ParticipantsPratik Shah - CEOPratik ShahI'm Pratik Shah, Chief Executive Officer of Design Therapeutics. During this presentation, we will use forward-looking statements with regards to our business, R&D activities, and financial conditions, which are subject to known and unknown risks and uncertainties. Actual results may differ materially due to various important factors, including those described in the risk fact ...